This message was sent to ##Email##
|
|
|
|
|
SCAI
SCAI's Emerging Leader Mentorship (ELM) Program, in partnership with the American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF), is accepting applications for the next wave of interventional/invasive cardiology leaders through Nov. 30!
SCAI's ELM Program is charged with finding a small, select group of up-and-coming physicians and facilitating their transition into the next generation of great thinkers, presenters, teachers and national leaders. ELM Fellows participate in six training sessions over a two-year period and will be assigned a panel of mentors specifically chosen to match their interests and aspirations.
Learn more about the ELM Program
Take a look at the 2015-2017 class of ELM Fellows
SCAI,
It is through the active representation of interventional cardiologists, through SCAI and the American Medical Association (AMA), that our specialty has an impact on the significant changes taking place across our nation's health care system. SCAI's strong representation in the AMA House of Delegates (HOD), the policymaking body of the AMA, allows us to have a collective voice through which we bring forth the interests of our specialty.
Twenty percent of SCAI's U.S. membership must also belong to the AMA, to retain our seat in the AMA House of Delegates and advisor status for the AMA CPT® Editorial Panel and Relative Value Scale Update Committee (RUC).
Save our seat! Activate your 2017 AMA membership today by visiting ama-assn.org/go/join or by calling 1-800-262-3211.
|
Promoted by
|
|
|
|
 |
SCAI
You're invited to join the interventional and invasive cardiovascular community for SCAI 2017 — a can't-miss celebration of our community's commitment to Save and Enhance Lives!
SCAI 2017 On Demand is now included in your registration for FREE! SCAI 2017 On Demand will capture presentation slides side-by-side with video of the speakers and can be viewed on the go from your smartphone or laptop. SCAI 2017 On Demand is a great way to make sure you don't miss a minute of SCAI 2017 content.
Early registration ends Dec. 16!
The Cardiology Advisor
Patients with advanced heart failure implanted with a centrifugal-flow pump had fewer reoperations for pump malfunction or replacement than patients with an axial-flow pump, according to six-month results from MOMENTUM 3.
READ MORE
Healio
Early feasibility studies are reviving device innovation in the United States, and offer several clinical advantages, as well as challenges, for interventional cardiologists, according to a speaker at TCT 2016. "Over the past two decades, from the standpoint of access to new device therapies, U.S. interventionalists have been stuck in the mud," Martin B. Leon, MD, founder and chairman emeritus of the Cardiovascular Research Foundation, said during a presentation.
READ MORE
 |
|
SHEATH PROFILE IN ITS CLASS1. SOLOPATH® RE-COLLAPSIBLE -- the first and only expandable and re-collapsible large bore femoral access sheath, with a lower insertion force and profile than the leading competitors.
Insert at a low profile
Expand to a predictable operating profile
Collapse and remove at a low profile
©2016 Terumo Medical Corporation. All rights reserved.
TIS-312-08102016
1. Data on File
|
|
MedPage Today
Recent findings on potentially preventable deaths may provide state officials with a better understanding of how to improve U.S. health goals and priorities, and also shine a spotlight on an unfavorable trend for fatal unintentional injuries, the Centers for Disease Control and Prevention (CDC) reported. Published in the CDC's "Morbidity and Mortality Weekly Report," an analysis of national data from 2014 found a significant decrease in the number of potentially preventable deaths among three of the five leading causes of death, compared with rates from 2010.
READ MORE
 |
|
PrognoCIS Electronic Health Record (EHR) and services use the latest internet technologies to provide efficient practice management and medical billing, meeting the needs of Cardiologists around the country.
Learn why our members say we’re “More Than a Great EHR.”
|
|
Healio
A transcatheter interatrial shunt device improved quality of life, improved exercise capacity and showed acceptable major adverse cardiovascular and cerebrovascular events rates at one year in patients with heart failure with preserved ejection fraction, according to a presentation at the American Heart Association Scientific Sessions. Data from the REDUCE LAP-HF study also showed patency of the shunt device (IASD System, Corvia Medical) as well as clinical and hemodynamic benefit at six months and one year.
READ MORE
Cardiovascular Business
After one year, the HeartLogic heart failure diagnostic service helped alert healthcare professionals of worsening heart failure in patients with cardiac resynchronization therapy defibrillator (CRT-D) systems, according to a multicenter, nonrandomized trial.
Lead researcher John P. Boehmer, MD, of the Pennsylvania State University College of Medicine, presented the results Nov. 16 in a late-breaking clinical trials session at the American Heart Association Scientific Sessions in New Orleans.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
For a complete list of job postings, click here.
To post your resume, click here.
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
